Controlled-Medicine Return-and-Destruction Director

The mandate

A product recall required retrieval of controlled medicines from patients, nurses and regional pharmacies, but collection records identified parcels while dispensing records identified patient, product, strength, pack and quantity. Partial packs, witnessed counts, failed collections, courier handovers and quarantine receipts could not be reconciled before destruction bookings. The defined problem is a secure reverse-custody and quantity architecture from authorised retrieval to witnessed destruction, not recall causation, patient treatment or general returns optimisation.

The deliverable is a controlled-medicine reverse-custody book containing recall and patient population, retrieval authority, coded identity, expected quantity, partial-pack count, tamper evidence, failed-collection escalation, courier custody, quarantine acceptance, discrepancy investigation, destruction witness and certificate reconciliation. Twelve historic cases and four live simulations form the casebook. Clinical decisions, recall declaration, legal interpretation, dispensing, waste licensing and vendor procurement are excluded.

Milestone one, at the end of week one, reconciles affected populations and twelve cases. Milestone two, at week two, delivers identity, count and handover states. Milestone three, at week three, runs four simulations covering absent patient, partial pack, damaged seal and depot discrepancy. Milestone four, at week four, submits the accepted custody book, regional training and 60-day corrective backlog.

Acceptance requires pharmacists, patient services, couriers, depots and destruction owners to reproduce expected, collected, received, quarantined and destroyed quantity for every simulation without exposing unnecessary patient identity. Discrepancies must trigger the same escalation and cannot close on parcel delivery alone. The chief pharmacist accepts when two regions run the full count independently, authorised security and legal owners confirm boundaries and every historic severity-one gap has a disposition.

The client will provide recall scope, dispensing and patient records, collection attempts, courier scans, witness counts, quarantine receipts, discrepancies, incident reports, destruction certificates, licences and current authorised procedures. It will nominate pharmacy, security, Privacy and Quality owners and secure six observations. Clinicians retain treatment; pharmacists retain medicine decisions; authorities retain reportability; licensed parties retain carriage and destruction; management retains vendor and recall authority.

Why this is external work

Patient teams protect care, couriers protect packages, depots protect stock and waste providers certify destruction, but no neutral owner joins their quantities and custody. Internal leaders are also managing the live recall and should not validate their own process. A short specialist engagement can establish defensible controls without becoming a controlled-drug operator or legal adviser.

What you will own

• Reconcile affected patient, prescription, product, strength, pack and expected-quantity populations using coded identity.
• Define retrieval, failed-attempt, count, seal, handover, quarantine, discrepancy and destruction evidence states.
• Trace twelve historic cases and identify where parcel status replaced controlled-medicine quantity or witness evidence.
• Run four simulations covering absent patient, partial pack, damaged seal and depot count disagreement.
• Design discrepancy escalation with clock, evidence owner, security trigger, reportability decision and closure authority.
• Separate custody architecture from clinical care, recall declaration, pharmacy judgement, legal interpretation and licensed destruction.
• Deliver the accepted reverse-custody book, case library, regional training and funded 60-day corrective backlog.

Candidate qualifications

• Designed controlled-drug, high-risk medicine or comparable secure reverse-custody operations across patient and licensed parties.
• Has reconciled partial packs, failed retrievals, handover counts, quarantine discrepancies and witnessed destruction during recall.
• Understands prescription identity, patient privacy, secure carriage, controlled storage, quantity witnesses and certificates operationally.
• Can create evidence controls without assuming clinician, pharmacist, authority, security or waste-license powers.
• Has rejected courier delivery as insufficient proof that recalled controlled quantity reached authorised quarantine.
• Delivered regional procedures that frontline teams used under patient sensitivity and strict discrepancy clocks.

Non-negotiables

• Can complete six patient-service, depot or destruction-site observations and four simulations within four weeks.
• Will remain independent of secure couriers, waste contractors, pharmacy vendors and recall service providers.
• Accepts clinician, pharmacist, Quality, Privacy, security, authority and licensed-destruction decision boundaries.
• Brings direct controlled-medicine custody; standard e-commerce returns or waste consulting alone is insufficient.

1. 49 words maximum. Describe a controlled-medicine return where parcel delivery failed to prove quantity custody.
2. 49 words maximum. How would you reconcile a partial patient pack without exposing unnecessary identity?
3. 49 words maximum. Which discrepancy must stop destruction until an authorised investigation owner acts?